Prostate Cancer Screening (Record no. 296597)

MARC details
000 -LEADER
fixed length control field 05269nam a22005895i 4500
001 - CONTROL NUMBER
control field 978-1-60327-281-0
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20160615111942.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100301s2009 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781603272810
-- 978-1-60327-281-0
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-60327-281-0
Source of number or code doi
049 ## - LOCAL HOLDINGS (OCLC)
Holding library Alfaisal Main Library
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC254-282
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED062000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.994
Edition number 23
245 10 - TITLE STATEMENT
Title Prostate Cancer Screening
Medium [electronic resource] /
Statement of responsibility, etc edited by Donna P. Ankerst, Catherine M. Tangen, Ian M. Thompson.
250 ## - EDITION STATEMENT
Edition statement Second Edition.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS
Place of production, publication, distribution, manufacture Totowa, NJ :
Name of producer, publisher, distributor, manufacturer Humana Press,
Date of production, publication, distribution, manufacture 2009.
300 ## - PHYSICAL DESCRIPTION
Extent XVI, 397 p.
Other physical details online resource.
336 ## - CONTENT TYPE
Content Type Term text
Content Type Code txt
Source rdacontent
337 ## - MEDIA TYPE
Media Type Term computer
Media Type Code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier Type Term online resource
Carrier Type Code cr
Source rdacarrier
347 ## -
-- text file
-- PDF
-- rda
490 1# - SERIES STATEMENT
Series statement Current Clinical Urology
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Trends in Prostate Cancer Screening -- Overview of US Prostate Cancer Trends in the Era of PSA Screening -- Trends in Prostate Cancer Screening: Overview of the UK -- Trends in Prostate Cancer Screening: Canada -- Trends in Prostate Cancer Screening – Overview of Europe -- Prostate-Specific Antigen -- Evolution of Prostate-Specific Antigen for Screening -- The Performance Characteristics of Prostate-Specific Antigen for Prostate Cancer Screening -- The Performance of PSA for Predicting Prostate Cancer After a Prior Negative Prostate Biopsy -- Subfractions and Derivatives of Total Prostate-Specific Antigen in the Early Detection of Prostate Cancer -- PSA Velocity at Presentation as a Predictor of Prostate Cancer Aggressiveness -- Risk Assessment for Prostate Cancer -- Nomograms for Prostate Cancer -- Decision Aid Criteria and Artificial Neural Networks for Optimizing Prostate Cancer Risk Prediction -- Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator -- Integration of Risk Assessment in Prostate Cancer Screening -- Family History of Prostate Cancer During Rapidly Increasing Incidence -- Recent Biomarkers for Prostate Cancer -- PSA Isoforms: [?2]proPSA Significant Adjunct to Free PSA -- PCA3 -- Transcriptional Profiling of Prostate Cancer: Biomarker Identification and Clinical Applications -- Biomarkers for Prostate Cancer Detection: Family-Based Linkage Analysis and Case–Control Association Studies -- GSTP1 Hypermethylation for Prostate Cancer Detection -- EPCA and EPCA-2 as Potential Biomarkers for Prostate Cancer Detection -- Design and Methodologic Considerations in Biomarker Studies -- Toward a Robust System for Biomarker Triage and Validation – EDRN Experience -- Statistical Evaluation of Markers and Risk Tools for Prostate Cancer Classification and Prediction -- Pitfalls in Prostate Cancer Biomarker Evaluation Studies -- Building upon Recently Completed and Ongoing Prospective Trials -- Prostate-Specific Antigen and Its Role on the Prostate Cancer Prevention Trial -- The Selenium and Vitamin E Cancer Prevention Trial -- PLCO: A Randomized Controlled Screening Trial for Prostate, Lung, Colorectal, and Ovarian Cancer -- The European Randomized Study of Screening for Prostate Cancer (ERSPC).
520 ## - SUMMARY, ETC.
Summary, etc More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Health informatics.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Urology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Epidemiology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine & Public Health.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Urology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Epidemiology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine/Public Health, general.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Health Informatics.
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
Source of term local
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ankerst, Donna P.
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tangen, Catherine M.
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thompson, Ian M.
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9781603272803
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Current Clinical Urology
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://ezproxy.alfaisal.edu/login?url=http://dx.doi.org/10.1007/978-1-60327-281-0">http://ezproxy.alfaisal.edu/login?url=http://dx.doi.org/10.1007/978-1-60327-281-0</a>
912 ## -
-- ZDB-2-SME
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type eBooks

No items available.

Copyright © 2020 Alfaisal University Library. All Rights Reserved.
Tel: +966 11 2158948 Fax: +966 11 2157910 Email:
librarian@alfaisal.edu